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The antiserum AS7 can specifically immunopreeipitate -Gi from membrane extracts as well as from a mixture of purified 
ct-Gi and a-Go as ascertained using [azP]ADP-ribosylated G-proteins. Using this antiserum to immunopreeipitate ~t-G~ 
from hepatocytes labelled with a2p it was evident that ~t-Gi was phosphorylated under basal (resting) conditions. Challen- 
ge of hepatocytes with the tumour promoting phorbol ester TPA, however, elicited a marked enhancement of the phos- 
phorylation state of ~t-Gi. This was accompanied by the loss of inhibitory effect of G~ on adenylate cyclase, as judged 
by the inability of low concentrations of p[NH]ppG to inhibit forskolin-stimulated adenylate cyclase activity. Such ac- 
tions were mimicked by treatment of hepatocytes with either glucagon or TH-glucagon, an analogue of glucagon which 
is incapable of activating adenylate cyclase and elevating intracellular cyclic AMP concentrations. Pre-treatment of hepa- 
tocytes with either glucagon, TPA or insulin did not affect the ability of pertussis toxin to cause the NAD +-dependent, 
[azP]ADP-ribosylation f a-Ga in membrane fractions isolated from such pre-treated hepatocytes. We suggest that protein 
kinase C can elicit the phosphorylation a d functional inactivation of ~t-G~ in intact hepatoeytes. As pertussis toxin only 
causes the ADP-ribosylation of the holomeric form of G~, it may be that phosphorylation leaves ct-Gi in its holomeric 
state. 
Adenylate cyclase; Guanine nucleotide regulatory protein; Phosphorylation; Phorbol ester; Protein kinase; Desensitization; Glucagon; 
(Hepatocyte) 
1. INTRODUCTION 
The functioning of many receptors i  mediated 
through the action of distinct guanine nucleotide 
regulatory proteins (G-proteins), which serve to 
couple receptors to their appropriate signal genera- 
tion system [1-3]. In the case of adenylate cyclase 
two distinct G-proteins are involved. These are Gs, 
which interacts with receptors which serve to 
stimulate adenylate cyclase, and Gi, which in- 
teracts with those receptors which inhibit the func- 
tioning of this enzyme. Both of these G-proteins 
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have been isolated and characterised as 
heterotrimers (a,fl,7) possessing apparently iden- 
tical ~,7 subunits but with distinct r-subunits. The 
ce-subunits of these two G-proteins can be iden- 
tified separately using cholera nd pertussis toxins, 
which cause the NAD+-dependent ADP- 
ribosylation of a-subunits of Gs and Gi, respective- 
ly [1-3]. Such toxins, however, can also interact 
with other G-proteins. One example is the G- 
protein Go, which is found in a number of cell 
types. This species is related to Gi in that it pro- 
vides a substrate for ADP-ribosylation by pertussis 
toxin but, however, does not inhibit adenylate 
cyclase [1-3]. 
Activation of Gs leads to the dissociation of its 
oe-subunit (cr-Gs) which interacts with and 
stimulates adenylate cyclase. Inhibition of 
adenylate cyclase, by Gi, is elicited both through 
the interaction of tr-Gi with adenylate cyclase and 
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by  the  re lease o f  f l ,7  subun i ts  f rom Gi, wh ich  in- 
h ib i t s  the  d i ssoc ia t ion  o f  Gs by  mass  ac t ion  [1 -3 ] .  
Incubat ion  o f  so lub i l i zed,  pur i f ied  Gi w i th  
pur i f ied  prote in  k inase  C has  been shown [4] to 
lead to  the  phosphory la t ion  o f  oe-Gi. S imi lar ly ,  we 
[5] and  o thers  [6] have  shown that  incubat ion  o f  
pure  preparat ions  o f  Gi and  Go wi th  a pur i f ied  
human insu l in  receptor  p reparat ion  leads to the 
phosphory la t ion  o f  ce-Gi. I t  has  been suggested 
that  phosphory la t ion  o f  Gi by  prote in  k inase  C 
may lead to  its inact ivat ion  as incubat ion  o f  
p late lets  w i th  tumour  promot ing  phorbo l  esters,  
wh ich  act ivate  prote in  k inase  C, b locked  the  abi l i ty  
o f  CeE-adrenoceptors to  inh ib i t  adeny la te  cyclase ac- 
t iv i ty  [7]. 
Here  we show that ,  under  rest ing cond i t ions ,  o~- 
Gi in hepatocytes  is in a phosphory la ted  state.  
Whi l s t  Gi is funct iona l  in membranes  prepared  
f rom these cells, the  pr io r  cha l lenge  o f  in tact  
hepatocytes  w i th  e i ther  TPA,  g lucagon or  TH-  
g lucagon,  an  ana logue  o f  g lucagon wh ich  does not  
s t imu la te  adeny la te  cyclase act iv i ty ,  led to an  in- 
crease in the  phosphory la t ion  s tate  o f  cr-Gi and  to 
its funct iona l  inact ivat ion .  
2. MATERIALS  AND METHODS 
Inorganic [32P]phosphate was obtained from Amersham In- 
ternational, Amersham, England. [32P]NAD+ was obtained 
from New England Nuclear, England. Collagenase type-II was 
from Worthington Biochemical Co., England. TPA was from 
Cambridge Bioscience, England. Hormones were from Sigma, 
England. All other biochemicals were from Boehringer Ltd, 
England. TH-glucagon was a kind gift from Drs V. Hruby and 
D. Trivedi, Dept of Chemistry, Univ. of Arizona, USA. Islet 
activating protein/pertussis toxin was from PHLS Centre for 
Applied Microbiology, Porton Down, England. Immunopre- 
cipitin (protein A) was obtained from BRL, England. All other 
chemicals were of AR grade from BDH Ltd, England. 
2.1. Hepatocyte preparation, incubation and harvesting 
Hepatocytes were prepared according to [8] using 225-250 g 
fed male Sprague-Dawley rats, as described before by us [9]. 
Cells (3-5 mg dry wt/ml) were preincubated at 37°C for at least 
50 min in Krebs Henseleit (50 ~tM potassium phosphate, 1 mCi 
32pi) buffer also containing 2.5070 BSA, 2.5 mM CaCI2 and 
10 mM glucose, and gassed with O2/COz (19.1) for 30 s every 
10 min. The ATP content of the isolated hepatocytes was deter- 
mined by the luciferase method on a neutralised HCIO4 extract 
[9]. 
Ligands were added to the incubation vessel in a volume 
which was less than 1 070 of the total incubation volume. After 
an appropriate time the reactions were stopped by addition of 
an equal volume of ice-cold buffer A, composed of 0.25 M 
sucrose, 10 mM Tris-HCl, final pH 7.4; 1 mM EDTA, 1 mM 
EGTA, 10 mM fl-glycerophosphate, 50 mM sodium fluoride, 
0.1 mM PMSF and 2 mM benzamidine. The cells were 
harvested by centrifugation at 1000 rpm for 3 min and washed 
twice in buffer A. After this procedure cells were taken for im- 
munoprecipitation f a-Gi. 
When cells were isolated for the purpose of adenylate cyclase 
assays, the hepatocytes were pre-incubated in normal Krebs 
Henseleit. Incubation of the hepatocytes was then quenched by 
adding an aliquot to an equal volume of ice-cold l mM 
KHCO3, pH 7.2 which was kept on ice until processed further 
as below. 
2.2. Preparation of liver and hepatocyte membranes 
A washed membrane fraction was obtained from the 
hepatocytes as detailed previously described by us [10]. In all 
cases membranes were used within 2 h of their preparation. In 
some experiments, membranes were prepared from whole liver 
homogenates [11]. 
2.3. Assay of adenylate cyclase 
Adenylate cyclase was assayed as described previously by us 
[9,11]. Assays contained (final concentrations) 1.5 mM ATP, 
5 mM MgSO4, 10 mM theophylline, 1mM EDTA, 7.5 mg 
phosphocreatine/ml, 1 mg creatine kinase/ml and 25 mM 
triethanolamine/KOH, pH 7.4. The cyclic AMP produced was 
assessed in a binding assay using cyclic AMP binding subunit of 
A-kinase [9,12]. Assays were linear under all conditions and in- 
itial rates were analysed. 
2.4. Labelling and assay of Gi 
Pertussis toxin-catalysed ADP-ribosylation both of purified 
Gi/Go and of isolated adipocyte and hepatocyte membranes 
was performed as before [13] using [3zP]NAD + and thiol pre- 
activated pertussis toxin. In some instances reactions were ter- 
minated by addition of ice-cold l0 mM Tris-HC1, pH 7.4, 
1 mM EDTA and taken for immunoprecipitation. I  others 
reactions were terminated by addition of Laemmli [14] sample 
buffer as described before [13], with subsequent electrophoresis 
and autoradiography. 
A mixture of purified soluble Gi/Go was prepared from 
bovine brain as described before by one of us [15]. 
Detection of functional Gi was assessed as before [13,16-18] 
by demonstrating the ability of low concentrations of 
p[NH]ppG (1 nM) to inhibit basal adenylate cyclase that had 
been previously amplified by the diterpene forskolin (100/~M). 
2.5. Immunoprecipitation f Gi 
Phosphorylated oe-Gi was immunoprecipitated using a 1 : 50 
dilution of AS7 antiserum [19], an antibody produced against 
the last 10 amino acids of the C-terminal end of rod transducin. 
This sequence differs in but a single amino acid from the 
equivalent C-terminal region of o~-Gi found in hepatocytes. This 
antiserum has been used successfully, by us, to identify oe-Gi n 
both purified and membrane preparations from these cells by 
immunoblotting [18]. 
In order to immunoprecipitate ce-Gi from hepatocytes a cell 
extract was first made. This involved taking 250/A of cells 
(50 mg protein) and adding them to 135 gl of PBS (10 mM 
KHEPO4/K2HPO4; pH 7.4, 0.9070 NaCl) and 100/~l of buffer B 
containing (final concentrations) 50 mM Tris-HCl, pH 7.4, 1070 
Triton X-100, 1070 Na deoxycholate, 0.1070 SDS, 1 mM EDTA, 
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0.15 M NaCI. To this mixture, 12.5/A Of gelatin (2070, w/v) was 
added and finally 2.5/zl of antiserum AS7 (1 : 200 dilution) add- 
ed and left at 4°C for 12 h. When purified Gi/Go was used for 
immunoprecipitation then 170 ng of a mixture of purified 
Gi/Go was present in 135/~l PBS and 100/d buffer B to which 
2.5/zl antiserum was added as detailed above. The mixture was 
then centrifuged at 4°C and 14000 × gav for 10 min to remove 
any insoluble material. The supernatant obtained subsequently 
was removed, and 25/A (w/v, 10070) protein A added to it and 
this mixture left at 4°C for 1.5 h. Samples were diluted 1 : 1 PBS 
prior to protein A being collected by centrifugation at 14000 × 
gay for 2 min at 4°C and washed once in PBS, then once in buf- 
fer B and finally once in PBS. 
2.6. SDS-PAGE and autoradiography 
The material immunoprecipitated using immunoprecipitin 
(protein A) was resuspended in Laemmli sample buffer [14] and 
placed in a boiling water bath for 3 min. After this time the 
samples were centrifuged for 2 min at 14000 x gay. The super- 
natants were taken for SDS-PAGE. This was performed for 2 h 
at 300 V and 60 mA using gels of 10% (v/v) acrylamide. After 
electrophoresis, the gels were fixed in 10°70 TCA for 1 h prior 
to drying and then subjected to autoradiography. The labelled 
bands of interest were excised from the gel and subjected to 
Cherenkov counting. 
3. RESULTS AND DISCUSSION 
We [13,18] and others [1,3,17] have shown 
previously, using a variety of methods, that 
hepatocyte plasma membranes contain ol-Gi. This 
can be detected functionally by employing low 
concentrations of p[NH]ppG to inhibit basal 
adenylate cyclase activity which has been amplified 
using the diterpene forskolin. This takes advantage 
of the fact that Gi has a higher affinity for 
p[NH]ppG than Gs, thus allowing Gi to be selec- 
tively activated [1-3,16]. oe-Gi has also been 
detected in hepatocyte membranes using pertussis 
toxin-catalysed ADP-ribosylation [13,20]. Similar- 
ly, the presence of ce-Gi has been determined in
hepatocytes u ing a specific antiserum (AS7) raised 
against he C-terminal decapeptide of the related 
G-protein, transducin [18]. 
The antiserum AS7 thus offers a potential means 
to detect whether ce-Gi s indeed phosphorylated in 
situ in the intact hepatocyte. In order to determine 
as to whether AS7 could be used to im- 
munoprecipitate ol-Gi specifically, we first attemp- 
ted to show whether AS7 could selectively 
immunoprecipitate cr-Gi from a mixture of 
purified Gi and its related G-protein Go. These 
proteins, which had been purified from bovine 
brain, were then labelled covalently by pertussis 
toxin-catalysed [32p]NAD-dependent ADP- 
ribosylation. Fig.1 shows that the antiserum AS7 
immunoprecipitated specifically the 41 kDa 
subunit hat is ce-Gi. Similarly, the antipeptide an- 
tiserum OC1, which interacts pecifically with o~- 
Go in Western blotting analyses [21], specifically 
immunoprecipitated he39 kDa cl-subunit of Go 
(fig. la). If non-immune/pre-immune antisera were 
employed in such experiments hen we failed to 
observe any label in the immunoprecipitate. Such 
an observation, coupled with the ability of AS7 
and OC1 to immunoprecipitate cr-Gi and a-Go 
selectively, indicates that these two antisera can be 
used for specific immunoprecipitations. Im- 
munoblotting with the antiserum OC1, however, 
showed that hepatocyte membranes did not appear 
to contain detectable concentrations of or-Go (not 
shown). 
In order that the ability of AS7 to im- 
munoprecipitate ol-Gi could be determined using 
solubilized membrane preparations, rather than 
purified components, we used pertussis toxin to 
label isolated membranes by [32p]ADP- 
ribosylation. Using AS7 we were able to show that 
this antiserum immunoprecipitated a [32p]ADP- 
ribosylated 41 kDa protein from these membranes 
(fig.lb). Again, normal rabbit serum/pre-immune 
serum failed to elicit any immunoprecipitation. 
When AS7 was used to immun0precipitate 
material from solubilized extracts of 32p-labelled 
hepatocytes then we observed a single labelled 
band which presumably reflected a,-Gi (fig.2). This 
suggests that ol-Gi is phosphorylated under 'nor- 
mal', basal conditions in intact hepatocytes. If,
however, hepatocytes were preincubated with the 
tumour-promoting phorbol ester TPA (10 ng/ml, 
15 min) then a marked increase in the degree of 
phosphorylation was observed (fig.2; table 1). This 
increase in phosphorylation was accompanied by a 
small decrease in the apparent mobility of ce-Gi on 
SDS-PAGE (fig.2). This could result from the 
presence of the negatively charged phosphate 
group, making oe-Gi migrate differently, perhaps 
by effecting a change in the conformation of ol-Gi 
or allowing it o bind a different amount of SDS. 
A small decrease in mobility of oe-Gi, upon SDS- 
PAGE, has also been noted by one of us [22] 
following pertussis toxin-catalysed ADP- 
ribosylation of ce-Gi. This small shift in mobility 
which accompanied the increased labelling of ce-Gi 
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Fig. 1. The antiserum AS7 specifically immunoprecipitates ol-Gi. 
(a) A purified, homogeneous preparation of Gi and Go, from 
bovine brain, was ADP-ribosylated using pertussis toxin and 
[32p]NAD+. This mixture was then incubated with either the 
antiserum AS7, which is specific for te-Gi, or with the antiserum 
OC1, which is specific for oe-Go. Immunoprecipitation a d 
subsequent analysis by SDS-PAGE and autoradiography was 
then performed as detailed in section 2. Track '1' shows the 
ADP-ribosylated mixture of Gi and Go before immunopre- 
cipitation, track '2' shows material immunoprecipitated by
might indicate that the TPA elicited phosphoryla- 
tion occurred on a site distinct from that which is 
phosphorylated under basal conditions. 
Presumably the effect of TPA is mediated here 
by its known ability to activate protein kinase C, 
which it does by mimicking the conformation of 
diacyl glycerol [23]. Such a contention would cer- 
tainly be consistent with previous observations [4] 
which have shown that pure preparations of Gi can  
be phosphorylated by protein kinase C. 
We also observed that if hepatocytes were 
treated with glucagon (10 nM, 5 min), then this 
too caused an increase in the phosphorylation state 
of ce-Gi (fig.2). Such an action could be mimicked 
using TH-glucagon (10 nM, 5 min), an analogue 
of glucagon which is incapable of both activating 
adenylate cyclase and of increasing the in- 
tracellular concentration of cyclic AMP in 
hepatocytes [24,25]. However, both glucagon and 
TH-glucagon have been shown capable of achiev- 
ing small stimulations of inositol phospholipid 
metabolism [25] and glucagon has been found to 
increase the intracellular concentration of 
diacylglycerol in intact hepatocytes [26]. Such 
observations would imply that both glucagon and 
TH-glucagon might rigger the phosphorylation f 
ce-Gi by producing diacylglycerol which subse- 
quently activates protein kinase C. 
The phosphorylation f ce-Gi which was elicited 
by these agents did not, however, affect he ability 
of pertussis toxin to catalyse the NAD+-de - 
pendent, [32p]ADP-ribosylation f cr-Gi in mem- 
brane fractions isolated from such pre-treated 
hepatocytes. As is shown in fig.3, the labelling of 
the 41 kDa ce-subunit of Gi was unaffected by pre- 
treatment with all of these various agents. This in- 
dicates that phosphorylation does not prevent 
ADP-ribosylation from occurring. Indeed, as per- 
OCI and track '3' material immunoprecipitated by AS7. oe-Gi 
migrated with an apparent molecular mass of 41 kDa and a-Go 
with that of 39 kDa. (b) Membranes were either ADP- 
ribosylated using pertussis toxin and [3zP]NAD + as in (track 2 
and track 3) or were not treated with pertussis toxin (track 1 and 
track 4). Membranes were then solubilized and subjected to 
immunoprecipitation as described above using either pre- 
immune serum (track 1 and track 2) or AS7 (track 3 and track 
4). Track '3' shows that ADP-ribosylated ot-Gi was 
immunoprecipitated and migrated as a single band with an 
apparent molecular mass of 41 kDa. This shows a typical 
experiment of one performed three times. 
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Table l 
Increase in phosphorylation of oe-Gi by treatment of 
hepatocytes with either TPA, glucagon or TH-glucagon 
a l~ G t 
Fig.2. The phosphorylation of ot-Gi in intact hepatocytes. 
Hepatocytes were labelled to equilibrium with ~2p. They were 
then challenged with one of TPA (10 ng/ml, 15 min), glucagon 
(10 nM, 5 min) or TH-glucagon (10 nM, 5 min). After this a 
solubilized membrane extract was made for immunoprecipita- 
tion analysis as described in section 2. This figure shows an 
autoradiograph of immunoprecipitates prepared using the 
antiserum AS7 (tracks 5-8), which immunoprecipitates a'-Gi, 
and an experiment using a control serum preparation (tracks 
1-4). Tracks '1,8' are with no challenge of the hepatocytes with 
ligands; tracks '2,7' after challenge with TPA; tracks '3,6' after 
challenge with TH-glucagon and tracks '4,5' after challenge 
with glucagon. This shows a typical experiment of one 
performed at least hree times using different cell preparations. 
It is clear that some phosphorylated proteins were precipitated 
non-specifically in this experiment, due to interaction with the 
immunoprecipitin, as shown in tracks 1-4. This shows a typical 
experiment of one performed three times. 
tussis toxin causes the ADP-ribosylation of Gi only 
when this G-protein is in its holomeric state [27] 
then the unchanged level of pertussis toxin- 
catalysed ADP-ribosylation of cr-Gi indicates that 
phosphorylation does not modify the interaction 
between oe-Gi and the ~'-7 complex which would 
lead to the dissociation of Gi. Furthermore, if
dissociation had occurred then one might have ex- 
pected ~'-subunits to have been released by 
pretreatment with the various ligands, which 
would lower the basal activity of adenylate cyclase 
activity; which is not the case [9,24]. 
The ability of TPA, glucagon and TH-glucagon 
to phosphorylate o -Gi may offer an explanation 
for our recent observations [28] that Gi function in 
hepatocytes is lost in membranes from cells which 
had been pre-treated with these ligands. Here we 
Ligand treatment % increase in labelling of a-Gi 
TPA 66.0 _+ 4.2 
TH-glucagon 77.5 _+ 17.6 
Glucagon 108.2 _+ 10.5 
Hepatocytes were labelled to equilibrium with 32p and then 
challenged with either TPA (10 ng/ml, 15 min), glucagon 
(10 nM, 5 min) or TH-glucagon (10 nM, 5 min). oe-Gi was 
immunoprecipitated using the antiserum AS7 and analysed by 
SDS-PAGE and autoradiography as described in section 2. The 
%-age increase in labelling of ct-Gi is shown relative to its 
labelling under basal (resting) conditions. Errors are SE for n = 
3 separate xperiments u ing different cell preparations. The 
degree of labelling was ascertained by Cherenkov counting of 
the radioactive bands which had been excised from the gels. 
Analysis of the 60 kDa phosphoprotein which was precipitated 
in experiments using both AS7 and non-specific antiserum 
showed that pre-incubation with the various ligands id not 
alter its level of phosphorylation (<10%) 
A B C D E 
Alpha G l 
Fig.3. Pertussis toxin catalysed ADP-ribosylation of ot-Gi in 
intact hepatocytes. Pertussis toxin catalysed ADP-ribosylation 
of oe-Gi was performed using isolated hepatocyte membranes 
and [3zP]NAD+, as described in section 2. Hepatocytes had 
been pre-treated beforehand for 5 rain at 30°C in the absence 
of any hormone (track A); insulin (10 nM) (track B); glucagon 
(10 nM) (track C); TPA (10 ng/ml for 15 min) (track D); no 
hormone (track E). 
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Table 2 
Inactivation of functional Gi by treatment of hepatocytes with 
ligands which stimulate the phosphorylation f oe-G~ 
Treatment of hepatocytes %-age inhibition of 
adenylate cyclase activity 
None 45 _+ 5 
TPA -3  _+ 3 
Glucagon - l0 _+ 7 
TH-glucagon -5  +_ 6 
Hepatocytes were either used untreated (control) or were 
treated with one of TPA (10 ng/ml, 15 min), glucagon (10 nM, 
5 min) and TH-glucagon (10nM, 5 min) prior to the 
preparation of a washed membrane fraction. This was used to 
assess functional Gi activity by monitoring the ability of low 
concentrations of p[NH]ppG to inhibit basal adenylate cyclase 
that had been amplified using the diterpene forskolin. Data 
shows the %-age inhibition elicited by l nM p[NH]ppG upon 
adenylate cyclase activity stimulated by 100,uM forskolin. 
Errors are SD for n = 3 experiments done on separate cell 
preparations. The specific activity of forskolin-stimulated 
adenylate cyclase activity was 62.3 _+ 4.5 pmol cAMP 
produced/min per mg membrane protein 
have assessed functional Gi by taking advantage of
the fact [1-3] that Gi has a much higher affinity 
for p[NH]ppG than has Gs. Thus, low concentra- 
tions of p[NH]ppG can be used to inhibit basal 
adenylate cyclase that has been amplified using the 
diterpene forskolin. Under the conditions used to 
elicit the phosphorylation f a-Gi then the ability 
of this G-protein to inhibit adenylate cyclase activi- 
ty is shown to be abolished (table 2). It would thus 
seem that the phosphorylation f oe-Gi, elicited by 
agents known to activate protein kinase C in intact 
cells, leads to the functional inactivation of ce-Gi. 
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